Metabolomics Profiles of Smokers from Two Ethnic Groups with Differing Lung Cancer Risk

Abstract

African American (AA) smokers are at a higher risk of developing lung cancer compared to whites. The variations in the metabolism of nicotine and tobacco-derived carcinogens in these groups were reported previously with the levels of nicotine metabolites and carcinogen-derived metabolites measured using targeted approaches. While useful, these targeted strategies are not able to detect global metabolic changes for use in predicting the detrimental effects of tobacco use and ultimately lung cancer susceptibility among smokers. To address this limitation, we have performed global untargeted metabolomics profiling in urine of AA and white smokers to characterize the pattern of metabolites, identify differentially regulated pathways, and correlate these profiles with the observed variations in lung cancer risk between these two populations. Urine samples from AA ( n = 30) and white ( n = 30) smokers were used for metabolomics analysis acquired in both positive and negative electrospray ionization modes. LC-MS data were uploaded onto the cloud-based XCMS online ( ) platform for retention time correction, alignment, feature detection, annotation, statistical analysis, data visualization, and automated systems biology pathway analysis. The latter identified global differences in the metabolic pathways in the two groups including the metabolism of carbohydrates, amino acids, nucleotides, fatty acids, and nicotine. Significant differences in the nicotine degradation pathway (cotinine glucuronidation) in the two groups were observed and confirmed using a targeted LC-MS/MS approach. These results are consistent with previous studies demonstrating AA smokers with lower glucuronidation capacity compared to whites. Furthermore, the d -glucuronate degradation pathway was found to be significantly different between the two populations, with lower amounts of the putative metabolites detected in AA compared to whites. We hypothesize that the differential regulation of the d -glucuronate degradation pathway is a consequence of the variations in the glucuronidation capacity observed in the two groups. Other pathways including the metabolism of amino acids, nucleic acids, and fatty acids were also identified, however, the biological relevance and implications of these differences across ethnic groups need further investigation. Overall, the applied metabolomics approach revealed global differences in the metabolic networks and endogenous metabolites in AA and whites, which could be used and validated as a new potential panel of biomarkers that could be used to predict lung cancer susceptibility among smokers in population-based studies.

Urinary Microbial and Metabolomic Profiles in Kidney Stone Disease

“…It has been reported that the accumulation of pyroglutamic acid could result in metabolic acidosis, which might promote stone formation ( Wagner and Mohebbi, 2010 ; Weiler et al., 2015 ). The other three metabolites were found to correlated with nicotine metabolism, anti-inflammation, and lipid metabolism ( Tan et al., 2019 ; Dator et al., 2020 ; Wojcieszyńska and Guzik, 2020 ). However, no related studies have reported the relationship between these metabolites and kidney stones, which should be investigated further to characterize their roles in the disease.…”

Metabolomics in Radiation Biodosimetry: Current Approaches and Advances

“…The ethnicity of the subject can also have an impact on metabolic signatures. For example, differences in the profiles of individual smokers were noted between African Americans and Caucasians [51].…”

Bridging the Polar and Hydrophobic Metabolome in Single-Run Untargeted Liquid Chromatography-Mass Spectrometry Dried Blood Spot Metabolomics for Clinical Purposes

“… 19 − 23 Although comprehensive analysis is provided, multi-separation approaches can be time-consuming and laborious, sometimes requiring extensive sample preparation procedures. Several single metabolomics methods have been developed for, e.g., plasma and urine analysis, with excellent results (see, e.g., refs ( 24 ) and ( 25 )). Broad range single methods are even beginning to merge different omics; He et al have recently combined lipidomics and proteomics with a single-shot technology.…”

“…A key challenge with analyses of biological samples is the wide polarity range of clinically relevant metabolites, ranging from, e.g., hydrophobic fatty acids to polar amino acids, often addressed by using several analytical methods/platforms, e.g., employing gas chromatography in addition to hydrophilic interaction liquid chromatography (HILIC) and reversed phase LC, to cover a broad part of the metabolome. − Although comprehensive analysis is provided, multi-separation approaches can be time-consuming and laborious, sometimes requiring extensive sample preparation procedures. Several single metabolomics methods have been developed for, e.g., plasma and urine analysis, with excellent results (see, e.g., refs and ). Broad range single methods are even beginning to merge different omics; He et al have recently combined lipidomics and proteomics with a single-shot technology .…”